As of Mar 22
| -0.29 / -2.01%|
The 5 analysts offering 12-month price forecasts for Nightstar Therapeutics PLC have a median target of 30.00, with a high estimate of 40.00 and a low estimate of 25.00. The median estimate represents a +112.01% increase from the last price of 14.15.
The current consensus among 4 polled investment analysts is to Buy stock in Nightstar Therapeutics PLC. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.